UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16
OR 15d-16
UNDER THE SECURITIES EXCHANGE
ACT OF 1934
For the month of June 2026
Commission File Number: 001-42453
Park Ha Biological Technology Co., Ltd.
901, Building C, Phase 2
Wuxi International Life Science Innovation Campus
196 Jinghui East Road
Xinwu District, Wuxi, Jiangsu Province
People’s Republic of China 214000
+86 400 012 7562
(Address of principal executive office)
Indicate by check mark whether the registrant files
or will file annual reports under cover of Form 20-F or Form 40-F.
Form
20-F ☒ Form
40-F ☐
Information Contained in this Form 6-K Report
Entry
Into Strategic Partnership with Star Plus Action (HK) Limited
On June 12, 2026, Park Ha
Biological Technology Co., Ltd. (the “Registrant”) announced that it had entered into a comprehensive strategic partnership
with Star Plus Action (HK) Limited, a wholly-owned subsidiary of Star Plus Legend Holdings Limited (6683.HK), a company
listed on The Stock Exchange of Hong Kong Limited.
The partnership is intended
to integrate resources in the healthcare industry, skincare product development, celebrity IP management, and artificial intelligence
technology to jointly advance the beauty and wellness sector. The collaboration spans multiple areas, including product development, IP
empowerment, AI agents, office scenarios, user operations, digital innovation, and global expansion. The parties have launched their first
collaborative smart product, the “AI Nutritionist,” and plan to accelerate the development and deployment of a full-chain
intelligent service system, including AI-powered store managers and AI-driven professional skincare specialists.
The foregoing description
is qualified in its entirety by the press release attached as Exhibit 99.1 to this Form 6-K.
Issuance of Press Release
On June 12, 2026, the Registrant
issued a press release announcing the strategic partnership described above. A copy of the press release is attached hereto as Exhibit
99.1.
Forward Looking Statements
Matters discussed in this
report may constitute forward-looking statements. Forward-looking statements include statements concerning plans, objectives, goals, strategies,
future events or performance, and underlying assumptions and other statements that are not historical facts. Words such as “believes,”
“expects,” “anticipates,” “estimates,” “projects,” “intends,” “plans,”
“will,” “would,” “should,” “could,” “may” or similar expressions identify
forward-looking statements. The forward-looking statements in this report are based upon various assumptions. Although the Registrant
believes that these assumptions were reasonable when made, because these assumptions are inherently subject to significant uncertainties
and contingencies that are difficult or impossible to predict and are beyond the Registrant’s control, the Registrant cannot assure
you that it will achieve or accomplish these expectations. Actual results may differ materially from those anticipated. The Registrant
undertakes no obligation to update or revise any forward-looking statements, except as required by law.
EXHIBIT INDEX
The following exhibit is being filed
herewith:
| Exhibit No. |
|
Description |
| 99.1 |
|
Press release of the Company dated June 12, 2026 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange
Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| |
Park Ha Biological Technology Co., Ltd. |
| |
|
|
| Date: June 12, 2026 |
By: |
/s/ Xiaoqiu Zhang |
| |
Name: |
Xiaoqiu Zhang |
| |
Title: |
Chief Executive Officer, Chairperson of the Board of Directors |
Exhibit 99.1
Park Ha Biological Technology Co., Ltd. announces
strategic partnership with Star Plus Legend Group’s wholly-owned subsidiary to build an AI-powered skincare and health ecosystem
and expand its healthcare reach.
Wuxi,
China, June. 12, 2026 (GLOBE NEWSWIRE) -- Park Ha Biological Technology Co., Ltd. (NASDAQ: BYAH) (“Park Ha
Biological” or the “Company”) announced that the Company has established a comprehensive strategic
partnership with Star Plus Action (HK) Limited (“Star Plus Action”), a wholly-owned subsidiary of Star Plus Legend
Holdings Limited (6683.HK), a company listed on The Stock Exchange of Hong Kong (“Star Plus Legend”). The two parties
will integrate resources in the healthcare industry, skincare product development, celebrity IP management, and artificial
intelligence technology to jointly advance the beauty and wellness sector, creating an innovative business model that combines AI
technology, professional skincare services, and health maintenance. Their first collaborative smart product—the AI
Nutritionist—has been launched as a pilot. Moving forward, both parties will accelerate the development and deployment of a
full-chain intelligent service system, including AI-powered store managers and AI-driven professional skincare specialists, driving
the digital transformation of the skincare and wellness industry.
With
the parallel growth of China’s beauty economy and health-conscious consumption trends, consumer demand has shifted from
standalone skincare products to integrated solutions combining skin care and health management. Leveraging years of research
expertise and market penetration, Park Ha Biological specializes in scientific skincare and premium wellness care, having
established a comprehensive product portfolio and customer service system that enjoys strong market credibility. To address industry
challenges such as product homogeneity and insufficient service precision, Park Ha Biological has partnered strategically with Star
Plus Action through complementary strengths, joint technological innovation, and shared service ecosystems, elevating the standards
for next-generation skincare and wellness services while delivering intelligent, personalized solutions.
Star Plus
Legend’s business model centers on IP creation and operation, leveraging IP to drive the synergistic development of AI-powered
robotics and innovative health lifestyle consumer products. In IP development, the company has established strong partnerships with
iconic figures like Jay Chou and Liu Genghong, creating phenomenal celebrity IPs such as “Zhou Classmate” and
“Coach Liu.” In 2023, it collaborated with top Hollywood special effects teams to develop the digital avatar “Zhou
Classmate” for Jay Chou, subsequently launching additional AI entities including the “Coach Liu” digital avatar,
an AI nutritionist, and an AI live stream host, thereby establishing a comprehensive intelligent service ecosystem. In the health
lifestyle sector, the company focuses on developing and selling health management products and skincare items, featuring brands such
as Motong (promoting low-carbon diets), Yingyang Doctor (balancing nutrition), and Doctor Moji (specializing in recombination
collagen).
This
collaboration spans multiple domains—including product development, IP empowerment, AI agents, offline scenarios, user operations,
digital innovation, and global expansion—to establish a comprehensive, long-term collaborative ecosystem.
Going
forward, both parties will continue to roll out the full range of AI-powered service solutions: AI-powered store managers will enable
intelligent management of online and offline touchpoints, customer traffic analysis, personalized recommendations, and automated after-sales
support, thereby enhancing store operational efficiency; AI-powered skincare specialists will perform smart skin analysis, identify skin
concerns, develop personalized skincare recommendations, and provide product pairing guidance, expanding the scope of beauty services
and making standardized, high-quality personalized skincare services accessible to a broader audience. All AI functions are intended for
general wellness and cosmetic purposes only and are not for medical diagnosis or treatment.
The
CEO of Park Ha Biological stated that this strategic collaboration represents a pivotal upgrade for the brand, transitioning from a
skincare-only focus to a comprehensive health and wellness ecosystem. Moving forward, the company will leverage its R&D
strengths, along with the IP resources, industrial expertise, and AI capabilities of Star Plus Legend, to continuously enhance
product offerings and intelligent service systems, thereby establishing a differentiated core competitive advantage in the
industry.
The full
implementation of this strategic collaboration is expected to help both parties break down traditional industry barriers, leverage technology
to drive industrial innovation, and reshape the healthcare and skincare sector. It may also establish an intelligent, international recognized
industry benchmark, and inject new momentum into the long-term, high-quality development of both parties.
About
Park Ha Biological Technology Co., Ltd.
Established
in 2016, Park Ha Biological Technology Co., Ltd. is primarily engaged in developing its private skincare label, direct skincare products
sales and franchise alliances promotions under the proprietary brand “Park Ha”, with a commitment to providing cost-effective
solutions to skin concerns and improving the confidence of women seeking skin treatment. As of April 30, 2025, the Company has three directly
operated stores and 39 franchisees, of which 38 and one operate under the store name “Park Ha” and “Geni” respectively,
in China. As part of its value-added service for the products, the Company offers “light beauty experience”, a quick complimentary
after-sales beauty service performed in the directly-operated stores and franchise stores. For more information, please visit the Company’s
website: http://ir.parkha.cn/.
Forward-Looking
Statements
Certain
statements in this announcement are forward-looking statements. These forward-looking statements involve known and unknown risks and uncertainties
and are based on the Company’s current expectations and projections about future events that the Company believes may affect its
financial condition, results of operations, business strategy and financial needs. Investors can find many (but not all) of these statements
by the use of words such as “approximates,” “believes,” “hopes,” “expects, “anticipates,”
“estimates,” “projects,” “intends,” “plans,” “will,” “would,”
“should,” “could,” “may” or other similar expressions in this announcement. The Company undertakes
no obligation to update or revise publicly any forward-looking statements to reflect subsequent occurring events or circumstances, or
changes in its expectations, except as may be required by law. Although the Company believes that the expectations expressed in these
forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions
investors that actual results may differ materially from the anticipated results and encourages investors to review other factors that
may affect its future results in the Company’s registration statement and other filings with the SEC.
For more
information, please contact:
Olivia Li
ir@parkha.cn
Park Ha
Biological Technology Co., Ltd.
